1)suspension[英][s?'spen?n][美][s?'sp?n??n]干混悬剂
1.Screening of the Zedoary turmeric oil suspension formulation by orthogonal design;正交设计筛选莪术油干混悬剂处方
2.Determination of cefaclor in cefaclor for suspension by HPCE;高效毛细管电泳法测定头孢克洛干混悬剂中头孢克洛的含量
3.Pharmacokinetics and bioequivalence of cefaclor for suspension after single dose administration in healthy volunteers健康受试者单剂量口服头孢克洛干混悬剂的药动学及生物等效性(英文)
英文短句/例句
1.Studies on Dry Suspension of Nitazoxanide and Compound Dry Suspension of Ivermectin;Nitazoxanide干混悬剂及伊维菌素复方干混悬剂的研究
2.DETERMINATION OF RELEVANT SUBSTANCES OF CEFACLOR SUSPENSION BY HPLC头孢克洛干混悬剂中有关物质的研究
3.Study on Exploration of Scutellarin Dry Suspension and Its Pharmacodynamics Effect Evaluation;灯盏花素干混悬剂的研究及其药效学评价
4.Taste masking and quality control of Cefprozil suspension掩味的头孢丙烯干混悬剂的制备及质量控制
5.Preparation and Quality Control of Taste-masked Cefprozil Dry Suspension掩味头孢丙烯干混悬剂的制备及质量控制
6.Bioequivalence of cefpodoxime proxetil for dry syrup in healthy male volunteers头孢泊肟酯干混悬剂人体生物等效性研究
7.Dissolution Test of Roxithromycin and Ambroxol Hydrochloride for Oral Suspension by Colorimetric Method比色法测定罗红霉素氨溴索干混悬剂的溶出度
8.Objective: To observe the relative bioavailability of clarithromycin dry suspension( RDS).目的观察口服克拉霉素干混悬剂的相对生物利用度。
9.Pharmacokinetics of Dry Suspension of Nitazoxanide in Dogs;硝唑尼特（Nitazoxanide）干混悬剂在狗体内的药物动力学研究
10.Determination of Ibuprofen and Sodium Phenobarbital in Compound Ibuprofen for Suspension by HPLCHPLC法测定复方布洛芬干混悬剂中布洛芬及苯巴比妥钠的含量
11.Titer Determination of Main Component in Kitasamycin Tablets and Acetylkitasamycin Dry Suspension by Turbidimetry浊度法测定吉他霉素片与乙酰吉他霉素干混悬剂中主药的效价
12.Development of the dissolution methods for roxithromycin granules and roxithromycin for suspension by HPLC罗红霉素颗粒和干混悬剂溶出度HPLC测定法的建立
13.A randomized double-blind controlled multicenter study with ibuprofen,pseudoephedrine and chlorphenamine for suspension in treatment of adult cold布洛伪麻那敏干混悬剂治疗成人感冒随机双盲对照多中心研究
14.Bioequivalence of ibuprofen,pseudoephedrine and chlorphenamine for tablet and suspension in healthy volunteers布洛伪麻那敏片和干混悬剂在健康人体内的生物等效性
15.Pharmacokinetics and Bioequivalence of Mycophenolate Mofetil Dry Suspension in Healthy Volunteers吗替麦考酚酯干混悬剂的人体药动学及生物等效性研究
16.Pharmacokinetics and Relative Bioavailability of Azithromycin Dried Suspension in Human Body阿奇霉素干混悬剂的人体药动学及生物等效性研究
17.Quantitative limitation of p-aminophenol for paracetamol sustained release suspension by HPLC对乙酰氨基酚缓释干混悬剂中对氨基酚限量的控制
18.Pharmacokinetics and bioequivalence of cefaclor for suspension after single dose administration in healthy volunteers健康受试者单剂量口服头孢克洛干混悬剂的药动学及生物等效性(英文)
相关短句/例句
dry suspension干混悬剂
1.Effect and safety of ivermectin dry suspension agent against sheep parasites;伊维菌素干混悬剂对绵羊寄生虫的驱杀效果与安全性研究
2.Objective To establish a HPLC method determing the content of racecadotril in racecadotril dry suspension.目的建立高效液相色谱法测定消旋卡多曲干混悬剂中消旋卡多曲含量的方法。
3.Objective To establish a HPLC method for determining the content of flurbiprofen in flurbiprofen dry suspension.目的建立高效液相色谱(HPLC)法测定氟比洛芬干混悬剂中氟比洛芬的含量。
3)NTZ dry suspensionNTZ干混悬剂
4)Oral Dry Suspensions口服干混悬剂
1.Suggestion on Dissolution of Indissolvable Drug Granules(Oral Dry Suspensions);关于拟定水难溶性药物颗粒剂(口服干混悬剂)溶出度检查的建议
5)Ibuprofen for Suspension布洛芬干混悬剂
6)composite pseudoephedrine hydrochloride dry suspension双酚伪麻干混悬剂
1.A simple and reliable reversed-phase high performance liquid chromatographic method (HPLC) for the routine analysis of pseudoephedrine hydrochloride and dextromethorphan hydrobromide in composite pseudoephedrine hydrochloride dry suspension has been established.建立了可同时测定双酚伪麻干混悬剂中盐酸伪麻黄碱和氢溴酸右美沙芬含量的反相高效液相色谱方法。
延伸阅读
硫酸钡（Ⅰ型）干混悬剂【通用名称】硫酸钡（Ⅰ型）干混悬剂【其他名称】硫酸钡（Ⅰ型）干混悬剂 硫酸钡（Ⅰ型）干混悬剂 拼音名：Liusuanbei(Ⅰxing) Ganhunxuanji 英文名：Barium Sulfate for Suspension(Type Ⅰ) 书页号：2000年版二部－886 本品为硫酸钡（Ⅰ型）加适当的分散剂及矫味剂制成的干混悬剂。 【性状】 本品为白色疏松的细粉；有香味。 【鉴别】 取本品约0.3g，照硫酸钡（Ⅰ型）项下的鉴别试验，显相同的反应。 【检查】 酸碱度 取本品100g，加水至100ml 制成混悬液后，依法测定（附录Ⅵ H），pH值应为5.5 ～7.5 。 稳定性 取本品100g，置 100ml具塞量筒中，加水至100ml ，密塞，充分振摇使成 混悬液，静置3 小时，混悬物的顶面不得下降至97ml的刻度以下。 颗粒细度 取本品0.5g，加水至50ml，充分振摇，放置10分钟后，倾去上清液，保 留约1ml ，立即取1 滴于载玻片上，在400 倍显微镜下检视3 个视野，绝大部分颗粒的 直径应在2μm以下，并不得有大于10μm 者。 干燥失重 取本品，在105 ℃干燥至恒重，减失重量不得过1.0 ％（附录Ⅷ L）。 表观黏度 取本品100g，加水至100ml 使成混悬液后，依法测定 (附录Ⅵ G第二法 ),用NDJ-1 型旋转式黏度计1号转子，每分钟60转，在25℃时的黏度不得过0.015Pa.s。 抗酸碱性 取表观黏度项下的混悬液，分别用盐酸溶液(9→100)和氢氧化钠试液调 节至pH值为1 及14时，立即用上法测定黏度，均不得过0.03Pa.s。 【类别】 同硫酸钡（Ⅰ型）。 【贮藏】 密封保存。
